Most linked-to pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #601 to #650.
- Pintumomab (2 links)
- Placulumab (2 links)
- Plasmid buffers (2 links)
- Platelet-derived growth factor receptor alpha (2 links)
- Platelet aggregation inhibitor (2 links)
- Plozalizumab (2 links)
- Pogalizumab (2 links)
- Polatuzumab vedotin (2 links)
- Polymyositis (2 links)
- Ponezumab (2 links)
- Prezalizumab (2 links)
- Priliximab (2 links)
- Pritoxaximab (2 links)
- Pritumumab (2 links)
- Programmed cell death 1 (2 links)
- Prostate cancer (2 links)
- Pseudomonas aeruginosa (2 links)
- Psoriasis (2 links)
- Psoriasis arthritis (2 links)
- Psoriatic Arthritis (2 links)
- Quilizumab (2 links)
- RANKL (2 links)
- RHD (gene) (2 links)
- RTN4 (2 links)
- Rabies (2 links)
- Racotumomab (2 links)
- Radretumab (2 links)
- Rafivirumab (2 links)
- Ralpancizumab (2 links)
- Ramucirumab (2 links)
- Ranibizumab (2 links)
- Raxibacumab (2 links)
- Real-time PCR (2 links)
- Refanezumab (2 links)
- Regavirumab (2 links)
- Renal cell carcinoma (2 links)
- Reslizumab (2 links)
- Respiratory syncytial virus (2 links)
- Retina (2 links)
- Retinopathy of prematurity (2 links)
- Rhesus factor (2 links)
- Rheumatoid arthritis (2 links)
- Rilotumumab (2 links)
- Rinucumab (2 links)
- Risankizumab (2 links)
- Rituximab (2 links)
- Rivabazumab pegol (2 links)
- Robatumumab (2 links)
- Roledumab (2 links)
- Romosozumab (2 links)